Abstract
Background: The National Survey on Drug Use and Health (NSDUH) estimated the prevalence of opioid use disorder (OUD) among the civilian, noninstitutionalized people aged 12 years or older in Massachusetts as 1.2% between 2015 and 2017. Accurate estimation of the prevalence of OUD is critical to the success of treatment and resource planning. Various indirect estimation approaches have been used but are subject to data availability and infrastructure-related issues. Methods: We used 2015 data from the Massachusetts Public Health Data Warehouse (PHD) to compare the results of two approaches to estimating OUD prevalence in the Massachusetts population. First, we used a seven-dataset capture-recapture analysis under log-linear model parameterization, controlling for the source dependence and effects of age, sex, and county through stratification. Second, we applied a benchmark-multiplier method in a Bayesian framework by linking health care claims data to death certificate data assuming an extrapolation of death rates from observed untreated OUD to unobserved OUD. Results: Our estimates for OUD prevalence among Massachusetts residents (aged 18-64 years) were 4.62% (95% CI = 4.59%, 4.64%) in the capture-recapture approach and 4.29% (95% CrI = 3.49%, 5.32%) in the Bayesian model. Both estimates were approximately four times higher than NSDUH estimates. Conclusion: The synthesis of our findings suggests that the disease surveillance system misses a large portion of the population with OUD. Our study also suggests that concurrent use of multiple methods improves the justification and facilitates the triangulation and interpretation of the resulting estimates. Trial registration: ClinicalTrials.gov Identifier: NCT04111939.
Original language | English |
---|---|
Pages (from-to) | 841-849 |
Number of pages | 9 |
Journal | Epidemiology |
Volume | 34 |
Issue number | 6 |
DOIs | |
State | Published - Nov 1 2023 |
Bibliographical note
Publisher Copyright:© 2023 Lippincott Williams and Wilkins. All rights reserved.
Funding
Supported by the National Institutes of Health and the Substance Abuse and Mental Health Services Administration through the NIH HEAL Initiative under award numbers UM1DA049406, UM1DA049412, UM1DA049415, and UM1DA049417 with additional support from the National Institute on Drug Abuse (DP2DA051864). The funder played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; nor the decision to submit the manuscript for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or its NIH HEAL Initiative.
Funders | Funder number |
---|---|
National Institutes of Health (NIH) | UM1DA049412, UM1DA049415, UM1DA049406, UM1DA049417 |
National Institutes of Health (NIH) | |
National Institute on Drug Abuse | DP2DA051864 |
National Institute on Drug Abuse | |
Substance Abuse and Mental Health Services Administration |
Keywords
- Bayesian benchmark-multiplier method
- Capture-recapture analysis
- Opioid use disorder prevalence estimation
- Surveillance data integration
ASJC Scopus subject areas
- Epidemiology